Cargando…

Serum Glucose and Fructosamine in Relation to Risk of Cancer

BACKGROUND: Impaired glucose metabolism has been linked with increased cancer risk, but the association between serum glucose and cancer risk remains unclear. We used repeated measurements of glucose and fructosamine to get more insight into the association between the glucose metabolism and risk of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wulaningsih, Wahyu, Holmberg, Lars, Garmo, Hans, Zethelius, Björn, Wigertz, Annette, Carroll, Paul, Lambe, Mats, Hammar, Niklas, Walldius, Göran, Jungner, Ingmar, Van Hemelrijck, Mieke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556075/ https://www.ncbi.nlm.nih.gov/pubmed/23372798 http://dx.doi.org/10.1371/journal.pone.0054944

Ejemplares similares

Serum calcium and risk of gastrointestinal cancer in the Swedish AMORIS study
por: Wulaningsih, Wahyu, et al.
Publicado: (2013)

Serum Lipids and the Risk of Gastrointestinal Malignancies in the Swedish AMORIS Study
por: Wulaningsih, Wahyu, et al.
Publicado: (2012)

Serum lactate dehydrogenase and survival following cancer diagnosis
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

Serum inflammatory markers and colorectal cancer risk and survival
por: Ghuman, Sundeep, et al.
Publicado: (2017)

Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study
por: Yiu, Andrew, et al.
Publicado: (2017)

Prediagnostic serum glucose and lipids in relation to survival in breast cancer patients: a competing risk analysis
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

Inorganic phosphate and the risk of cancer in the Swedish AMORIS study
por: Wulaningsih, Wahyu, et al.
Publicado: (2013)

Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort
por: Shackshaft, Lydia, et al.
Publicado: (2017)

Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort
por: Melvin, Jennifer C, et al.
Publicado: (2017)

Iron metabolism and risk of cancer in the Swedish AMORIS study
por: Gaur, Anjali, et al.
Publicado: (2013)

Serum Calcium and the Risk of Breast Cancer: Findings from the Swedish AMORIS Study and a Meta-Analysis of Prospective Studies
por: Wulaningsih, Wahyu, et al.
Publicado: (2016)

Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival
por: Wulaningsih, Wahyu, et al.
Publicado: (2016)

Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serum
por: Ghoshal, Arunangshu, et al.
Publicado: (2017)

Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
por: Arthur, Rhonda, et al.
Publicado: (2016)

Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort
por: Bosco, Cecilia, et al.
Publicado: (2018)

Metabolic profiles to predict long-term cancer and mortality: the use of latent class analysis
por: Santaolalla, Aida, et al.
Publicado: (2019)

Serum biomarkers to predict risk of testicular and penile cancer in AMORIS
por: Ghoshal, Arunangshu, et al.
Publicado: (2017)

Fructosamine Is a Useful Indicator of Hyperglycaemia and Glucose Control in Clinical and Epidemiological Studies – Cross-Sectional and Longitudinal Experience from the AMORIS Cohort
por: Malmström, Håkan, et al.
Publicado: (2014)

Can pre-diagnostic serum levels of sodium and potassium predict prostate cancer survival?
por: Ghoshal, Arunangshu, et al.
Publicado: (2018)

Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study
por: Sollie, Sam, et al.
Publicado: (2020)

Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study
por: Sollie, Sam, et al.
Publicado: (2019)

Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity
por: Wulaningsih, W., et al.
Publicado: (2018)

Serum leptin, C‐reactive protein, and cancer mortality in the NHANES III
por: Wulaningsih, Wahyu, et al.
Publicado: (2015)

Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory
por: Van Hemelrijck, Mieke, et al.
Publicado: (2016)

Association between serum markers of the humoral immune system and inflammation in the Swedish AMORIS study
por: Santaolalla, Aida, et al.
Publicado: (2021)

Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study
por: Kessler, Anna, et al.
Publicado: (2019)

Cardiovascular events in patients under age fifty with early findings of elevated lipid and glucose levels – The AMORIS study
por: Ivert, Torbjörn, et al.
Publicado: (2018)

A systematic review of the literature exploring the interplay between prostate cancer and type two diabetes mellitus
por: Crawley, Danielle, et al.
Publicado: (2018)

Correction: Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women
por: Wulaningsih, Wahyu, et al.
Publicado: (2016)

Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women
por: Wulaningsih, Wahyu, et al.
Publicado: (2016)

Prospective study of Type 2 diabetes mellitus, anti‐diabetic drugs and risk of prostate cancer
por: Häggström, Christel, et al.
Publicado: (2016)

Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer
por: Crawley, Danielle, et al.
Publicado: (2016)

Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study
por: Crawley, Danielle, et al.
Publicado: (2018)

Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-up
por: Grundmark, Birgitta, et al.
Publicado: (2011)

Serum Total Bilirubin and Risk of Cancer: A Swedish Cohort Study and Meta-Analysis
por: Monroy-Iglesias, Maria J., et al.
Publicado: (2021)

Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
por: Lind, Viktor, et al.
Publicado: (2021)

Risk of thromboembolic diseases in men with prostate cancer: results from the population-based PCBaSe Sweden
por: Van Hemelrijck, Mieke, et al.
Publicado: (2010)

Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area
por: Grundmark, Birgitta, et al.
Publicado: (2014)

Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study
por: Lin, E., et al.
Publicado: (2020)

Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study
por: Lin, E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7oousrj4gviiat44n6ku6au0du